Patents by Inventor Rajinder Kumar

Rajinder Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Authentication-based communication link with a peripheral device
    Patent number: 11792651
    Abstract: Methods, systems, computer-readable media, and apparatuses for an authentication-based communication link with a peripheral device are presented. In some embodiments, the peripheral device receives, from a host device, and stores, in a memory of the peripheral device, registration data including, for instance, a user credential, a user identifier, and/or a device identifier. Upon a request to pair the peripheral device with the same or a different host device, the peripheral device requests and receives, from such a host device, authentication data including a user credential, a user identifier, and/or a device identifier. The peripheral device determines whether a match exists between the received authentication data and the registration data. If so, a communication link is established with the host device.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: October 17, 2023
    Assignee: QUALCOMM Incorporated
    Inventors: Rajinder Kumar, Naga Chandan Babu Gudivada, Prakash Tiwari, Ravisagar Pyarasani, Pradeep Cherukoori, Phani Vemula, Rajesh Vundavalli
  • AUTHENTICATION-BASED COMMUNICATION LINK WITH A PERIPHERAL DEVICE
    Publication number: 20220022030
    Abstract: Methods, systems, computer-readable media, and apparatuses for an authentication-based communication link with a peripheral device are presented. In some embodiments, the peripheral device receives, from a host device, and stores, in a memory of the peripheral device, registration data including, for instance, a user credential, a user identifier, and/or a device identifier. Upon a request to pair the peripheral device with the same or a different host device, the peripheral device requests and receives, from such a host device, authentication data including a user credential, a user identifier, and/or a device identifier. The peripheral device determines whether a match exists between the received authentication data and the registration data. If so, a communication link is established with the host device.
    Type: Application
    Filed: July 17, 2020
    Publication date: January 20, 2022
    Inventors: Rajinder KUMAR, Naga Chandan Babu GUDIVADA, Prakash TIWARI, Ravisagar PYARASANI, Pradeep CHERUKOORI, Phani VEMULA, Rajesh VUNDAVALLI
  • INHIBITORS OF DNA GYRASE FOR THE TREATMENT OF BACTERIAL INFECTIONS
    Publication number: 20170197935
    Abstract: The present invention relates to compounds which specifically inhibit bacterial DNA Gyrase and can be used for the treatment of respiratory tract infections.
    Type: Application
    Filed: March 23, 2017
    Publication date: July 13, 2017
    Inventors: Chandrasekhar Alapati, Surobhi Lahiri, Radha Rangarajan, Rajinder Kumar
  • Inhibitors of DNA gyrase for the treatment of bacterial infections
    Patent number: 9643979
    Abstract: The present invention relates to compounds which specifically inhibit bacterial DNA Gyrase and can be used for the treatment of respiratory tract infections.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: May 9, 2017
    Assignee: Vitas Pharma Research Private Limited
    Inventors: Chandrasekhar Alapati, Ankita Banerjee, Radha Rangarajan, Rajinder Kumar
  • INHIBITORS OF DNA GYRASE FOR THE TREATMENT OF BACTERIAL INFECTIONS
    Publication number: 20150284408
    Abstract: The present invention relates to compounds which specifically inhibit bacterial DNA Gyrase and can be used for the treatment of respiratory tract infections.
    Type: Application
    Filed: October 8, 2013
    Publication date: October 8, 2015
    Inventors: Chandrasekhar Alapati, Ankita Banerjee, Radha Rangarajan, Rajinder Kumar
  • Heterocyclic compounds as inhibitors of fatty acid biosysnthesis for bacterial infections
    Patent number: 9115149
    Abstract: The present invention relates to novel heterocyclic compounds which specifically inhibit bacterial FabI and can be used for the treatment of Staphylococcal infections.
    Type: Grant
    Filed: September 18, 2012
    Date of Patent: August 25, 2015
    Assignee: VITAS PHARMA RESEARCH PRIVATE LIMITED
    Inventors: Radha Rangarajan, Rajinder Kumar, B V Prabhakar, P Chandrasekhar, P Mallikarjuna, Ankita Banerjee
  • HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FATTY ACID BIOSYSNTHESIS FOR BACTERIAL INFECTIONS
    Publication number: 20140249170
    Abstract: The present invention relates to novel heterocyclic compounds which specifically inhibit bacterial FabI and can be used for the treatment of Staphylococcal infections.
    Type: Application
    Filed: September 18, 2012
    Publication date: September 4, 2014
    Inventors: Radha Rangarajan, Rajinder Kumar, BV Prabhakar, P Chandrasekhar, P Mallikarjuna, Ankita Banerjee
  • BALAGLITAZONE COMPOSITIONS AND METHODS
    Publication number: 20130109620
    Abstract: Methods for reducing bone loss in a subject suffering from a condition benefiting from a decrease in insulin resistance, by balaglitazone administration to the subject.
    Type: Application
    Filed: December 17, 2010
    Publication date: May 2, 2013
    Applicants: RHEOSCIENCE A/S, REDDY'S LABORATORIES, LIMITED
    Inventors: Bente Riis, Kim Henriksen, Rajinder Kumar
  • Process for preparing solid dosage forms of very low-dose drugs
    Publication number: 20030129246
    Abstract: A drug formulation process which comprises admixing carrier particles with a solution of drug in water in a quantity of 1-3% by weight of solution to total mix and a method of treatment and/or prophylaxis of dementia, which method comprises administering to the patient [R-(Z)]-&agr;-(methoxyimino)-&agr;-(1-azabicyclo [2.2.2]oct-3-yl)acetonitrile monohydrochloride at a daily dose below 0.01 mg/kg and pharmaceutical compositions used therein.
    Type: Application
    Filed: February 26, 2003
    Publication date: July 10, 2003
    Applicant: SmithKline Beecham p.l.c.
    Inventors: James Albert Napper, Karen Triona O'Brien, Sultan James Manek, Rajinder Kumar, Julia Mary Loudon, Michael Sydney George Clark, Neil Mortimer
  • Process for preparing solid dosage forms of very low-dose drugs
    Publication number: 20020150618
    Abstract: A drug formulation process which comprises admixing carrier particles with a solution of drug in water in a quantity of 1-3% by weight of solution to total mix and a method of treatment and/or prophylaxis of dementia, which method comprises administering to the patient [R-(Z)]-&agr;-(methoxyimino)-&agr;-(1-azabicyclo [2.2.2]oct-3-yl)acetonitrile monohydrochloride at a daily dose below 0.01 mg/kg and pharmaceutical compositions used therein.
    Type: Application
    Filed: June 10, 2002
    Publication date: October 17, 2002
    Applicant: SmithKline Beecham p.l.c.
    Inventors: James Albert Napper, Karen Triona O'Brien, Sultan James Manek, Rajinder Kumar, Julia Mary Loudon, Michael Sydney George Clark, Neil Mortimer
  • Process for preparing solid dosage forms of very low-dose drugs
    Publication number: 20010018074
    Abstract: A drug formulation process which comprises admixing carrier particles with a solution of drug in water in a quantity of 1-3% by weight of solution to total mix and a method of treatment and/or prophylaxis of dementia, which method comprises administering to the patient [R-(Z)]-&agr;-(methoxyimino)-&agr;-(1-azabicyclo [2.2.2]oct-3-yl)acetonitrile monohydrochloride at a daily dose below 0.01 mg/kg and pharmaceutical compositions used therein.
    Type: Application
    Filed: January 12, 2001
    Publication date: August 30, 2001
    Applicant: SmithKline Beecham p.l.c.
    Inventors: James Albert Napper, Karen Triona O'Brien, Sultan James Manek, Rajinder Kumar, Julia Mary Loudon, Michael Sydney George Clark, Neil Mortimer